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Title: Comparing population estimates for drug users, the prevalence of blood 
borne viruses and the provision of services in one London borough: evidence of a 
gap in provision? 
 
 
Abstract: 
 
Aims 
To estimate the size of the drug using population in Lambeth, an inner city London 
borough, and the prevalence of blood borne virus (BBV) infections in the drug using 
population. To identify possible shortfalls in service provision for drug users.  
 
Methods 
Direct and indirect estimates of the drug using population size using national and 
local data sources. Prevalence estimates for BBV infections were derived from local 
survey data. Routine data and a survey of borough services for drug users were 
compiled.  
 
Findings 
Based on indirect methods we estimate there were 3117 drug users in Lambeth in 
2001/2 (20 per 1000 15-44 year olds), of whom 1641 were injecting users (11 per 
1000); 1353 were reported as being in drug treatment programmes. BBV prevalence 
rates: hepatitis B, 37%; hepatitis C, 71%; HIV, 6%. Estimated demand for needle 
exchange services, in terms of one syringe per injection, and methadone maintenance 
may be up to double local provision.  
 
Conclusions 
More accurate and feasible methods are needed for the routine estimation of the 
population of drug users. Accurate information is needed for service planning.  
 
 
(Word Count: 181) 
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Title: Comparing population estimates for drug users, the prevalence of blood 
borne viruses and the provision of services in one London borough. A gap in 
provision? 
 
 
 
Introduction 
 
Recent British government health policy has emphasised the importance of 
developing a series of minimum standards and long term strategies for the provision 
of disease specific services. This process began with the publication in 1999 of the 
National Service Framework for Mental Health (Department of Health, 1999) and 
now covers a range of chronic diseases. A similar process has covered the 
management of patients with drug misuse problems.  
 
In 2003, the National Treatment Agency for Substance Misuse, a government body, 
published a document describing a national framework for commissioning services 
for drug users. Termed, ‘Models of Care for the Treatment of Drug Misusers’ 
(National Treatment Agency, 2003), this document offers a detailed description of the 
panoply of services required to address the health problems associated with drug 
misuse. One chapter is devoted to the issue of blood borne viral (BBV) infections. 
 
Hepatitis B, hepatitis C and HIV infection are the most common blood borne viral 
infections frequently associated with injecting drug use. Injecting drug users may be 
protected from all three infections by avoiding blood or semen contact with infected 
individuals. Transmission of infection may be prevented by ensuring that those who 
are infected do not share needles, syringes and other injecting paraphernalia, and that 
they practice safe sex. Vaccination is available to protect against hepatitis B and 
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primary care vaccination programmes for drug users have been recommended (Royal 
College of General Practitioners, 2005).  
 
Prevalence rates for blood borne viral infections vary considerably across the country, 
as does service provision for their prevention and management. Hickman and 
colleagues (2004) noted high rates of hepatitis C infection among drug users and 
calculated that syringe and needle distribution was adequate for less than one third of 
all injections. Conversely, harm reduction interventions in the UK, including syringe 
exchange provision, have contributed towards maintaining a low prevalence of HIV 
(Stimson, 1995).  
 
We therefore aimed to quantify the current size of the drug using population in 
Lambeth, an inner city highly deprived London borough with previously reported 
high rates of drug use (Hickman et al, 1999). Secondly, we aimed to determine the 
prevalence of blood borne viral infections in this population. Thirdly, we aimed to 
describe service provision for these drug users. Finally, by comparing substance user 
population estimates and blood borne virus prevalence values with service provision, 
we aimed to quantify the shortfall in services required to meet the needs of these drug 
users. 
 
Methods 
The following data sources were utilised to provide prevalence estimates:  
• National Drug Treatment Misuse Service (NDTMS) (National Drug Treatment 
Monitoring Service, 2002) publishes data on the numbers of drug users 
registered with treatment programmes; 
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• The Office of National Statistics (ONS) publishes data on drug related deaths 
(Office of National Statistics, 2000);  
• Unlinked Anonymous Prevalence Monitoring Programmes (UAPMP) which 
monitors HIV, hepatitis B and C prevalence rates in six national cohorts 
including injecting drug users (IDUs) (Health Protection Agency, 2004); 
• The Health Protection Agency co-ordinates a survey of HIV infection 
diagnosed (SOPHID) that began in 1995. The survey covers England, Wales 
and Northern Ireland and is the only source of national data on patients with 
HIV infection who are accessing HIV related care (Health Protection Agency, 
2003); 
• British Crime Survey (BCS) which interviews over 50,000 people each year 
about crime and crime-related issues (Aust et al, 2002); 
• Community recruited survey data was used to obtain indirect estimates of drug 
user prevalence (Hickman et al, 2004); 
• Other local survey data (see below, under ‘Mapping local services’). 
 
Most data relate to 15-44 year olds, the peak decades for drug use.  
 
Indirect prevalence estimates 
Direct prevalence estimates of illicit drug misuse based on population surveys may be 
unreliable because of reporting bias due to the illegal nature and ‘underground’ 
culture associated with it. Indirect methods estimate the unobserved part of the drug 
using population in a variety of ways, based on an analysis of the observed part 
(Hickman et al, 1999, 2003). We used both multiplier and capture-recapture 
techniques in this study to allow cross validation of the prevalence estimates 
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(Hartnoll, 1997). An average number and population rate of users was calculated from 
the individual estimates. 
 
Multiplier methods take data on numbers of users in contact with a known data source 
(the benchmark) and derive an estimate of the total population using the proportion of 
users known to the data source (the multiplier) (Frischer, 2004; Hartnoll et al, 1985). 
For example by applying an observed multiplier (1% = annual mortality rate among 
injecting drug users, Davoli et al, 1997) to the number of drug-related deaths in 
Lambeth (29 = benchmark: ONS), the total number of drug users is estimated as 29 x 
100/1 = 2900. The multiplier in this example, although derived from a different 
population, is robust enough to use in other settings (Frischer, 2001; Hartnoll, 1997). 
 
This method was also undertaken using the following pairs of data: a) proportion of 
drug users in treatment (national multiplier: Godfrey et al, 2002) and the number in 
treatment locally (benchmark: NDTMS); b) the proportion of users who access needle 
exchange (local multiplier: Hickman et al, 2004) and the number of clients using this 
service (benchmark: local data – see below); and c) the HIV infection rate among 
injecting drug users (local multiplier: UAPMP) and the number of known HIV 
positive injectors (benchmark: SOPHID). 
 
Capture-recapture methods (CRM) have been promoted for use with difficult to reach 
populations (Hickman et al, 1999). Their use in epidemiological studies for estimating 
under-ascertainment or adjusting population surveys and estimates has been described 
in detail by others (Domingo-Salvany, 1997; Hook and Regal, 1995). 
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To identify and match drug users in at least two data sources, a number of identifiers 
(initials, date of birth and sex) are used. The data sources are combined into a single 
dataset (in SPSS) which is used to create three way (contingency) tables showing the 
number of cases in one or more data sources. The tables are then analysed in STATA 
using Poisson regression (log linear methods) to model potential dependencies 
between datasets (Hook and Regal, 1995) and find the simplest model with the best fit 
(Hickman et al, 2004). For example, CRM assumes that  each person is no more likely 
to be in one dataset than another (independence), but in reality an individual may be 
more (positive dependence) or less likely (negative dependence) to appear in one or 
more lists. Dependencies between epidemiological and health data sources are 
inevitable but using this approach to analysis allows for adjustment for the effects of 
these dependencies (Hook and Regal, 1995). 
 
Mapping local services 
A summary of all services available to drug users in the borough was compiled. 
Services provided by community drug teams, primary care and secondary care drug 
services were mapped. Data gathering involved semi-structured interviews with 
service providers in Lambeth and reviewing local publications in the grey literature 
(Patton, 2004; Figueroa-Munoz, 2000; The Stockwell Project, 2001; Taylor, 2003). 
 
Results 
Drug user prevalence estimates 
Data from the national datasets and from local information using direct and indirect 
prevalence estimates are summarised in Tables 1 and 2. Estimates of drug user 
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prevalence derived from these multiple data sources and which apply to our study 
setting, are displayed in the final column of both tables.  
 
Blood borne virus prevalence estimates in drug users 
The prevalence of hepatitis B, hepatitis C and HIV infections in drug users, both 
nationally and in our local study setting, is summarised in Table 3. 
 
Service provision 
Needle exchange programme 
Injecting drug users (IDUs) attend any one of six needle exchange sites in Lambeth. 
In total, this service distributes around 660,000 needles per year to 1000 known 
clients. However, we have estimated that the true population of IDUs is 1641 (Table 
2).  
 
Based on the assumption that users inject a median frequency of 2.5 times a day (Judd 
et al, 2005) for 300 days per year, the number of needles required to prevent any 
sharing or re-use in this population is 1.2 million. To meet this need would require an 
approximate doubling of current service provision. However, users are often reluctant 
to collect large quantities of needles and syringes due to the risk of arrest; and an 
increase in ‘drug litter’ may raise community concerns if distribution is increased. 
 
Methadone maintenance programme 
The total capacity for methadone maintenance treatment in Lambeth was found to be 
sufficient for 1000 patients. Almost 600 patients were part of a methadone 
maintenance programme in primary care and a further 400 patient treatment slots 
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were identified in secondary care. Our estimate for numbers of opiate users (1461) 
suggests a 50% shortfall in current service provision. 
 
Discussion 
Main findings 
The mean estimate for the prevalence of injecting drug use in Lambeth in 2001/02, 
using indirect methods, was 11 per 1000 young adults. This is a similar, albeit slightly 
lower estimate, than those of other local studies (13 per 1000: Hickman et al, 1999, 17 
per 1000 Hickman et al, 2004). Comparable figures for opiate (9.7 per 1000) and 
crack use (8.8 per 1000) are lower than for injecting drug use. This is unlikely to be 
the case as most injectors will use opiates but not all opiate users are injectors. 
Understandably there are greater problems with the accuracy of recording data on 
illegal drug users (which depends upon voluntary completion of registration forms) 
than there are for needle exchange derived data (which merely requires a count of 
needles dispensed).  
 
The multiplier method may under- or over-estimate local prevalence depending on the 
multiplier used and the accuracy of the benchmark. One of our estimates for injecting 
users (617) was derived from an HIV dataset and is in fact lower than the number of 
known injectors (1000). Limitations of the HIV multiplier method include 
assumptions that all HIV-infected injectors are recorded, and that these individuals are 
still injecting (Frischer, 2001). Inclusion of this value has reduced our overall estimate 
for injecting users which was derived from three sources. The true number of 
injecting users is therefore likely to be higher than our calculated mean estimate.   
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The direct estimates also appear to significantly underestimate the prevalence of 
opiate and crack use (table 1). This underestimate is likely to be attributable to under-
reporting among the small number of injecting and other drug users who are included 
in the British Crime Survey. The high value for all Class A drug use stems from the 
data gathering process which results in inclusion of all drug users including those with 
no medical problems, as well as recreational users.  
 
The prevalence of blood borne viral infections in IDUs is considerably higher in 
Lambeth than nationally (table 3). HIV rates are thirty times higher than the national 
figure, and rates may now be approaching 1.6% (Health Protection Agency, 2006). 
The prevalence of hepatitis C infection is as high as 80% among the Portuguese 
injecting community of Lambeth (Sad, 2003). With more virus circulating among 
users, high risk injecting practices such as needle sharing will inevitably lead to an 
increase in transmission, infection and ultimately healthcare costs.   
 
In terms of service shortfall, we found the estimated opiate use in Lambeth to be 
around 50% greater than the capacity for methadone maintenance treatment.  Injecting 
drug users probably require double the numbers of needles that local services are 
currently providing. Sharing of needles and syringes remains high, for example 
among the Portuguese community in Lambeth 100% of injecting users had shared 
needles in the last month (Health Protection Agency, 2003). To what extent this risky 
behaviour can be reduced by effective service provision is not known, and should be 
further explored. 
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Whether this hypothesised shortfall in service provision translates into increased risk 
of blood borne virus infection arising from needle sharing is uncertain. It is possible 
that, faced with an inadequate needle supply, the injecting user may resort to needle 
re-use rather than needle sharing. Re-use without needle sharing may give rise to 
other concerns such as septicaemia from dirty needles but cross-infection would be 
minimised.  Some commercially available products are now available that support re-
use, for example coloured syringe plungers to allow users to identify their own 
‘works’.  
 
Although this study only considered BBV infections, the local context gives rise to 
wider concern about the infection risks in an IDU community where needle sharing is 
a relatively common practice.  In 2002, there was an outbreak of group A 
streptococcal septicaemia among IDUs in Lambeth. The source of infection may have 
been related to contamination of drugs carried in the mouth or between the buttocks (a 
practice known as ‘plugging’) (Cowan, 2004). Bacterial transmission via shared 
needles has also been reported (Kolokithas & Rao, 1997).  
 
Implications of findings for other geographical areas 
Drug user population estimates are essential for forecasting the needs of current users 
and planning appropriate service provision. The methods used in this study, 
particularly the capture-recapture and multiplier methods, have been employed 
elsewhere, both for local and national (including Home Office) estimates of drug use 
(Hartnoll, 1985; Hickman, 1999, Frischer, 2001). However, for a small area study 
such as this we would expect variation in the different estimates, and as such we have 
used cross validation and comparison with other studies to corroborate our findings. 
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Our final estimates are credible which suggests the methods are transferable at a 
primary care trust level. 
 
Inevitably, the local setting for a population survey is, to some extent, unique. 
Lambeth’s population is young, has a high proportion of ethnic minority residents 
(‘White British’ comprise 49.6% of the population; Afro-Caribbeans, the largest 
ethnic minority group in Lambeth, represent 25.8% of the local population; the 
Portuguese are the largest group of new arrivals) and social deprivation is high (the 
21
st
 most deprived local authority in England) (Annual Public Health Report, 
Lambeth PCT, 2004). Several local public health concerns overlap with the issues 
raised by our survey of drug users and BBV prevalence. For example, Lambeth has 
the largest proportion of HIV positive residents of any borough in England (7% of the 
population in 2002) and high levels of all sexually transmitted infections (Annual 
Public Health Report, Lambeth PCT, 2004). Lambeth is clearly not a ‘typical’ English 
borough. Nevertheless, many of the methodological issues of our survey apply to 
other areas. The methodology of population sampling and generating population 
estimates does not depend on the population being representative for England as a 
whole and can readily be applied to other areas, even if the final estimate generated by 
this approach was unique to Lambeth. Similarly, the complexity of obtaining accurate 
population estimates and the need for multiple data sources applies regardless of 
setting. 
 
Not only are the social characteristics of Lambeth very different to those of England 
as a whole, but drug users themselves differ from the local population. The NDTMS 
data source used in our survey (National Drug Treatment Monitoring Service, 2002) 
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also provided demographic information about all users attending drug services in 
Lambeth. Based on this information, the local ratio of male to female drug users 
reflects that in the rest of the country at around three to one, and most users are above 
25 years old.  The NDTMS data source also reported that in 2001/02, 73% of users 
were ‘white’, 15% were ‘black’ (here, this term includes mixed black, black British, 
black Caribbean, black African and black other) and data were missing for 5%. The 
majority of white users seen at most services may either be a true reflection of the 
drug using population or have arisen because of differential use of services by ethnic 
groups or the result of inconsistent collection of ethnicity data. 
 
The proportion of Portuguese residents in Lambeth is high (upper estimates of 10%), 
and among these are many young IDUs (Figueroa-Munoz, 2000). At one north 
Lambeth needle exchange 25% of registered clients were Portuguese (Stockwell 
Project, unpublished data). Other ‘ethnic groups’ identified among drug users include 
Italian and Somali, while among sex-working women Albanian, Czech and Thai 
nationalities are common (Taylor, 2003). 
 
A review of the national literature (Fountain et al, 2003) concluded that clients from 
different ethnic backgrounds may be deterred from attending drug user services 
because of cultural inappropriateness, language barriers, location and opening times. 
Drug using women may also be deterred from accessing ‘establishment’ services due 
to fears around childcare issues (White et al, 2001).  
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Taken together, these examples of certain groups who access services less readily, 
suggest that our estimates of drug user prevalence are likely to be underestimates and 
any shortfall in provision of services is likely to be correspondingly larger.  
 
Recommendations 
The difficulties of accurate estimation of prevalence are hardly surprising, arising as 
they do from a combination of the illegal nature of drug use, the client’s wish for 
anonymity and problems with the provision of data by drug services. However, the 
general difficulties in obtaining information are compounded by the lack of local 
information on which to base service planning. To overcome this, a common tool for 
the assessment of physical health could be devised and community drug teams asked 
to collaborate with reporting drug related health problems and behaviours to specialist 
commissioners. For this reason, a health needs assessment form is now used in 
Lambeth which ascertains current physical health, BBV status (current condition, 
willingness to be tested, immunisation status), risk behaviours and data on substance 
use (type, quantity, frequency and route of administration). Other areas might wish to 
develop their own simple assessment forms designed to provide the exact information 
needed for service planning. 
 
Conclusion 
The population estimates suggest a possible shortfall between service provision and 
the needs of drug users, particularly injecting drug users.  Coupled with high rates of 
BBVs in Lambeth, this shortfall may contribute to increasing local rates of hepatitis 
and HIV infections among drug users (Health Protection Agency, 2006). We support 
the expansion of needle exchange services, along with adequate methadone 
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maintenance therapy and hepatitis vaccination, to help control this growing problem. 
However, any proposal for increased service provision must be based on accurate 
estimates of the population of drug users and our survey has demonstrated how 
difficult it is to obtain such information, even using multiple data sources, 
sophisticated techniques such as multiplier and capture-recapture methods, and 
combined direct and indirect prevalence estimates.  
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Table 1: Direct drug user prevalence estimates for Lambeth, 2001/02. 
 
Indicator Data source Overall population 
estimate
a
 
Rate per 1000
b
 
All drug use (in treatment) NDTMS 1353 9 
Class A drug use
c 
 BCS 7245 39 
Opiate use  BCS 327 1.8 
Crack use  BCS 400 2.2 
a 
Estimate based on Lambeth population 15 – 44 years of 150,594 (2001 Census) 
b 
NDTMS figures for 15 – 44 year olds in Lambeth notified as in treatment; BCS figures for 15 – 59 year olds  
c  
Heroin, morphine, cocaine, ecstasy, LSD 
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Table 2: Indirect drug user prevalence estimates for Lambeth, 2001/02. 
 
Indicator Data source Multiplier 
(%) 
Bench-
mark 
Estimated
number 
of users 
Mean 
population 
estimate 
Mean 
rate per 
1000
a 
All drug 
use 
NDTMS 33  1353 4063  
21.0 
 
Deaths (ONS) 1 29  2900 3117 
CRM
b
 n/a n/a 2400  
Injecting 
drug use  
Exchange
c
 41   1000 2439   
11.0 
 
HIV
d
 6 37 617 1641 
CRM
b
 n/a n/a 1868  
Opiate use 
NDTMS 42 463 1057  
9.7  CRM
b
 n/a n/a 1861 1461 
Crack use 
NDTMS 42 297 707  
8.8 CRM
b
 n/a n/a 1927 1318 
 
a 
Estimate based on Lambeth population, 15 – 44 years, of 150,594 (2001 Census) 
b 
Capture recapture method 
c 
Needle and syringe exchange (Lambeth), (Hickman et al, 2004) 
d 
SOPHID and UAPMP 
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Table 3: Proportion of drug users infected with blood borne viruses 
 
Area Hepatitis B (%) Hepatitis C (%) HIV (%) 
Lambeth 37 71 6.0 
England and Wales 30 38 0.2 
Source: UAPMP (2003) 
 
 
